Prof. Dr. Nicholas D. James
The STAMPEDE trial is the largest trial to date of abiraterone as first line therapy for advanced prostate cancer in nearly 2,000 men.
The STAMPEDE trial is the largest trial to date of abiraterone as first line therapy for advanced prostate cancer in nearly 2,000 men.